Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
about
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaGetting to 90-90-90 in paediatric HIV: What is needed?Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014.The association between quality of HIV care, loss to follow-up and mortality in pediatric and adolescent patients receiving antiretroviral therapy in NigeriaAssociation between age at antiretroviral therapy initiation and 24-month immune response in West-African HIV-infected childrenMissed opportunities for early access to care of HIV-infected infants in Burkina FasoViral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling studyPediatric Human Immunodeficiency Virus Continuum of Care: A Concise Review of Evidence-Based Practice.Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programsImmunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries.Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.Long-term outcomes of a pediatric HIV treatment program in Maputo, Mozambique: a cohort study.Retention of HIV-Infected Children in the First 12 Months of Anti-Retroviral Therapy and Predictors of Attrition in Resource Limited Settings: A Systematic Review.Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References.Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes.Implementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.Missed opportunities of inclusion in a cohort of HIV-infected children to initiate antiretroviral treatment before the age of two in West Africa, 2011 to 2013.Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity studyImmediate antiretroviral therapy in young HIV-infected children: benefits and risks.Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in IndiaMorbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009.Reasons for hospitalization in HIV-infected children in West AfricaCLINICAL outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study.Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study.Improving estimates of children living with HIV from the Spectrum AIDS Impact Model.Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic.The global burden of oral diseases in pediatric HIV-infected populations: a workshop report.Lost to follow-up: failure to engage children in care in the first three months of diagnosis.Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation.Targeting 90-90-90--don't leave children and adolescents behind.The Voices That Influence HIV-Positive Mothers' Breastfeeding Practices in an Urban, Ghanaian Society.Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.Using Observational Data to Inform HIV Policy Change for Children and YouthHigh loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South AfricaSimulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and Adolescents
P2860
Q28535251-3C16FE6A-B18E-44A0-B611-672CE0385633Q30385352-5BB7724A-D02D-43A1-8629-318329EB4352Q33722976-208D5BA6-213D-487C-9962-850C8D705BCCQ33777533-8EBF4E77-D6E9-4FC6-96EB-A0EE480143F3Q33974971-A44D5576-7303-4B51-A3E8-C7B3ACF7D522Q34214526-91905CA7-6676-4690-A026-8E121E73D992Q34434570-4C166FE4-C5F0-4EC9-9223-7382AE8AF08EQ34508454-6CECDE95-745F-4708-803E-4CE72534D77CQ34682648-29A5FDC9-C9F8-483B-841B-4A51FF32B5EBQ35148237-BDBD7628-8CA0-432B-A40F-F8B6B3519C80Q35152574-2BDFCDF0-4F93-46F1-9BD6-6DD6F484C91AQ35248842-2EEF9107-D782-46C3-B7A2-C9CAA7CC001EQ35738443-AA46A52D-ACCA-4D7A-8EC5-D7D09F8A745EQ35872045-674D7EC5-57E9-4261-B037-C7DE6FB67F7AQ35969206-A0ACBEFE-22F5-4D23-9E64-4887ACC7F9DEQ36046415-EAD806FE-ACC6-4F2E-903D-40DC4C6586B5Q36062366-D47CA941-7EF1-4EC1-B07C-6820219B3970Q36282732-3A77CAB0-3D50-47D0-9C4F-9EC48F19E310Q36291142-7C59C440-2183-4644-A0B6-F1399F62D6CBQ36294353-6ACF490A-911E-43D9-83DF-A6AC9747920FQ36729941-134E55F9-93CF-48A3-9CE9-DD1DC929A05BQ36930477-C0A97A4A-1A74-41E1-A2B6-C9A250388AEFQ37403284-5C400E94-1417-4254-9586-2C52DD0A6627Q37652234-3D89AF94-5320-4EA6-A8D0-32A816AC3AA3Q37695745-27E42CAA-7F32-4DF3-A19D-3C1FB13A572FQ37723712-4028EB89-9547-470F-A5F9-EF9A06E47C44Q37726969-873AA2E4-70F9-4D82-993D-12E8920B80C1Q37730863-2D13098A-43F4-4FA0-84B6-E8525237972AQ38744152-39FE0FA2-F090-4BEA-87BF-B76313646529Q38771867-72EACCE1-029F-4225-8C3C-24A34AE15AFFQ38907470-9464D413-AEAB-4DE1-A233-1117A89A997CQ39782151-8DA10411-4A65-4CC7-B5E1-6D397A966C15Q40223405-4195A4FE-7A17-4191-AC70-0CD3FCAA50DDQ41071212-C7B60612-05B5-44F0-8282-0011F9ADDEB6Q43142354-4886A000-F62C-44C3-B75F-5AD6277B68CDQ47571136-8B6E94DD-820F-412D-B092-3CE95056B00BQ53283586-99AB2FCA-431B-42BF-A96B-8D3251E3BFE8Q56888618-B5121120-93BC-4825-B674-104469686C65Q56925786-6CECD265-066F-4A5D-B1FE-F791A1BEB5C8Q57169257-453661B1-4D89-4C70-A78E-BF6841AAA778
P2860
Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Outcomes of antiretroviral the ...... c multiregional collaboration.
@ast
Outcomes of antiretroviral the ...... c multiregional collaboration.
@en
type
label
Outcomes of antiretroviral the ...... c multiregional collaboration.
@ast
Outcomes of antiretroviral the ...... c multiregional collaboration.
@en
prefLabel
Outcomes of antiretroviral the ...... c multiregional collaboration.
@ast
Outcomes of antiretroviral the ...... c multiregional collaboration.
@en
P2093
P2860
P50
P1476
Outcomes of antiretroviral the ...... c multiregional collaboration.
@en
P2093
Azar Kariminia
Edmond Aka
Fatoumata Dicko
Haby Signaté-Sy
International IeDEA Pediatric Working Group1
Karen Malateste
Linda Aurpibul
Pagakrong Lumbiganon
Samuel Ayaya
Samuel Phiri
P2860
P304
P356
10.1097/QAI.0B013E31827B70BF
P407
P50
P577
2013-02-01T00:00:00Z